— Know what they know.
Not Investment Advice

ICCC NASDAQ

ImmuCell Corporation
1W: -1.8% 1M: -2.5% 3M: -3.1% YTD: +64.7% 1Y: +47.7% 3Y: +80.6% 5Y: -0.1%
$9.75
+0.15 (+1.56%)
 
Weekly Expected Move ±3.1%
$9 $9 $10 $10 $10
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $88.2M mcap · 6M float · 0.431% daily turnover · Short 28% of daily vol

Balance Sheet Trends

Total Assets
$43M -5.7% ▼
5Y CAGR: +1.1%
Total Liabilities
$11M -34.6% ▼
5Y CAGR: -1.0%
Shareholders Equity
$27M -1.7% ▼
5Y CAGR: -0.9%
Cash & Investments
$4M +1.3% ▲
5Y CAGR: -13.7%
Total Debt
$6M -62.2% ▼
5Y CAGR: -11.9%
Net Debt
$2M -83.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$10M$6M$979K$4M$4M
Short-Term Investments-$468$0$0$0$0
Cash & ST Investments$10M$6M$979K$4M$4M
Net Receivables$3M$2M$2M$4M$3M
Inventory$3M$6M$8M$7M$9M
Other Current Assets$0$0$40K$0-$3M
Total Current Assets$16M$14M$11M$15M$13M
Property, Plant & Equip.$28M$31M$32M$30M$0
Goodwill & Intangibles$172K$153K$134K$115K$96K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$26K$77K$58K$33K$25M
Total Non-Current Assets$28M$31M$32M$30M$26M
Total Assets$44M$45M$44M$45M$43M
— Liabilities —
Accounts Payable$745K$790K$888K$944K$0
Short-Term Debt$812K$1M$1M$1M$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$307K$0$2M
Total Current Liabilities$3M$3M$4M$4M$4M
Long-Term Debt$8M$9M$11M$9M$4M
Other Non-Current Liab.$0$0$0$0$4M
Total Non-Current Liabilities$9M$11M$15M$13M$8M
Total Liabilities$12M$14M$19M$18M$11M
— Equity —
Common Stock$781K$781K$781K$904K$911K
Retained Earnings-$4M-$6M-$12M-$14M-$15M
Accumulated OCI-$0-$0-$0$0$0
Total Stockholders Equity$33M$30M$25M$28M$27M
Total Liabilities & Equity$44M$45M$44M$45M$43M
— Key Metrics —
Total Debt$10M$12M$17M$15M$6M
Net Debt$89K$7M$16M$11M$2M
Total Investments-$468$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms